Dr. Solomon will discuss several areas in his presentation:
1. The concept of morbidities in rheumatoid arthritis;
2. Specific morbidities including cardiovascular disease, diabetes, and hyperlipidemia; and
3. Whether morbidities should be viewed as cause or effect with respect to rheumatoid arthritis.
The discussion will focus on current scientific developments and how they pertain to rheumatology practice.
Disclosure of Interest D. Solomon Grant/research support from: Amgen, Lilly, Pfizer, Genentech, Bristol Myers Squibb
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.